Literature DB >> 27226630

Unraveling Growth Factor Signaling and Cell Cycle Progression in Individual Fibroblasts.

Sean M Gross1, Peter Rotwein2.   

Abstract

Cultured cells require the actions of growth factors to enter the cell cycle, but how individual members of a population respond to the same stimulus remains unknown. Here we have employed continuous monitoring by live cell imaging in a dual-reporter cell model to investigate the regulation of short-term growth factor signaling (protein kinase B (PKB/Akt) activity) and longer-term progression through the cell cycle (cyclin-dependent kinase 2 activity). In the total population, insulin-like growth factor-I (IGF-I)-enhanced cell cycle entry by >5-fold compared with serum-free medium (from 13.5 to 78%), but at the single cell level we observed a broad distribution in the timing of G1 exit (4-24 h, mean ∼12 h) that did not vary with either the amount or duration of IGF-I treatment. Cells that failed to re-enter the cell cycle exhibited similar responses to IGF-I in terms of integrated Akt activity and migration distance compared with those that did. We made similar observations with EGF, PDGF-AA, and PDGF-BB. As potential thresholds of growth factor-mediated cell cycle progression appeared to be heterogeneous within the population, the longer-term proliferative outcomes of individual cells to growth factor stimulation could not be predicted based solely on acute Akt signaling responses, no matter how robust these might be. Thus, although we could define a relationship at the population level between growth factor-induced Akt signaling dynamics and cell cycle progression, we could not predict the fate of individual cells.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Akt PKB; cell proliferation; cell signaling; growth factor; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 27226630      PMCID: PMC4938184          DOI: 10.1074/jbc.M116.734194

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor.

Authors:  Mark J Mulvihill; Andrew Cooke; Maryland Rosenfeld-Franklin; Elizabeth Buck; Ken Foreman; Darla Landfair; Matthew O'Connor; Caroline Pirritt; Yingchaun Sun; Yan Yao; Lee D Arnold; Neil W Gibson; Qun-Sheng Ji
Journal:  Future Med Chem       Date:  2009-09       Impact factor: 3.808

2.  Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states.

Authors:  K Wesley Overton; Sabrina L Spencer; William L Noderer; Tobias Meyer; Clifford L Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

3.  Akt signaling dynamics in individual cells.

Authors:  Sean M Gross; Peter Rotwein
Journal:  J Cell Sci       Date:  2015-06-03       Impact factor: 5.285

4.  The response of human epithelial cells to TNF involves an inducible autocrine cascade.

Authors:  Kevin A Janes; Suzanne Gaudet; John G Albeck; Ulrik B Nielsen; Douglas A Lauffenburger; Peter K Sorger
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

Review 5.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

Review 6.  Distinct and overlapping functions of insulin and IGF-I receptors.

Authors:  J Nakae; Y Kido; D Accili
Journal:  Endocr Rev       Date:  2001-12       Impact factor: 19.871

7.  The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit.

Authors:  Sabrina L Spencer; Steven D Cappell; Feng-Chiao Tsai; K Wesley Overton; Clifford L Wang; Tobias Meyer
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

Review 8.  The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.

Authors:  Michelle C Mendoza; E Emrah Er; John Blenis
Journal:  Trends Biochem Sci       Date:  2011-04-30       Impact factor: 13.807

Review 9.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

Review 10.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

View more
  6 in total

Review 1.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

2.  Adipose-derived stem cell-conditioned medium protects fibroblasts at different senescent degrees from UVB irradiation damages.

Authors:  Shu Guo; Ting Wang; Shuangyi Zhang; Peng Chen; Zheng Cao; Wenqin Lian; Jiayan Guo; Yue Kang
Journal:  Mol Cell Biochem       Date:  2019-10-10       Impact factor: 3.396

3.  Quantification of growth factor signaling and pathway cross talk by live-cell imaging.

Authors:  Sean M Gross; Peter Rotwein
Journal:  Am J Physiol Cell Physiol       Date:  2017-01-18       Impact factor: 4.249

4.  SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.

Authors:  Sergiy Sukhanov; Yusuke Higashi; Shaw-Yung Shai; Patricia Snarski; Svitlana Danchuk; Veronica D'Ambra; Michael Tabony; T Cooper Woods; Xuwei Hou; Zhaohui Li; Atsufumi Ozoe; Bysani Chandrasekar; Shin-Ichiro Takahashi; Patrice Delafontaine
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

5.  The role of insulin in transdifferentiated hepatocyte proliferation and function in serum-free medium.

Authors:  Ce Gu; Panpan Li; Wei Liu; Yan Zhou; Wen-Song Tan
Journal:  J Cell Mol Med       Date:  2019-04-04       Impact factor: 5.310

Review 6.  Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling.

Authors:  Zhixiang Wang
Journal:  Cells       Date:  2021-11-26       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.